All funds
HIV HEDEF PORTFÖY YÖNETİMİ A.Ş. SUNİNVEST GİRİŞİM SERMAYESİ YATIRIM FONU
+3.03%
past month
Summary
HIV primarily holds yatırım fonu katılma payı. It manages 23.0M ₺ in assets across 7 investors. (Average position: ~3.3M ₺)
Fund Size
23.0M ₺
Total portfolio value
Net Flow
+2.4M ₺
monthly net in/out
Management Fee
—
Charged from the fund whether you gain or lose.
Max Expense Ratio
—
Annual cap for all expenses.
Withholding
%0–17,5
Varies by holding period.
Withholding — By Holding Period
- 2 yıldan az tutulursa 17.5%
- 2 yıldan çok tutulursa 0.00%
No withholding on the gain when a REIF/VCIF is held for 2 years or more.
- Yatırım Fonu Katılma Payı 100%
Purchasing Power
₺ TÜFE
Period
Loading…
Nominal Return · —
—
Unit-share return for the selected period. Pick a benchmark on the chart for purchasing power.
Return
1 Month +3.03%
📋 Profile
ISIN code TRYHDFP01183
Founder HEDEF PORTFÖY YÖNETİMİ A.Ş.
Umbrella fund HEDEF PORTFÖY YÖNETİMİ A.Ş. GİRİŞİM SERMAYESİ ŞEMSİYE FONU
Umbrella type GİRİŞİM SERMAYESİ ŞEMSİYE FONU
Portfolio manager firm HEDEF PORTFÖY YÖNETİMİ A.Ş.
Fund term 12 YIL
Independent auditor HSY DANIŞMANLIK VE BAĞIMSIZ DENETİM A.Ş.
📞 Contact
ContactBarbaros Mah. Ihlamur Blv. No: 3, Daire: 217, Ataşehir/İstanbul
Tel0212 970 8570
Faks0212 970 8561
Authorized contacts
Yasin ÇETİN Pazarlama Müdürü
0 (212) 970 8572 yasin.cetin@hedefportfoy.com.tr
Fund Profile
What is the HIV fund?
HIV is a real-estate or venture-capital fund managed by Hedef Portföy. It is tracked under the code HIV, in the Girişim Sermayesi Yatırım Fonları category.
What does the HIV fund hold?
Portfolio allocation: Yatırım Fonu Katılma Payı 100%.
How much withholding tax does the HIV fund carry?
Withholding is charged on the gain and ranges %0–17,5, depending on how you exit:
- 2 yıldan az tutulursa %17.5
- 2 yıldan çok tutulursa %0
Rates are estimates; consult your tax advisor about your own situation.
Not investment advice
The information here is for informational purposes only and is not investment advice. Past performance does not guarantee future results. Source: TEFAS.